Author
Listed:
- Sebastian Dütting
(Institute of Experimental Biomedicine, University Hospital and University of Würzburg
Rudolf Virchow Center, University of Würzburg)
- Frederique Gaits-Iacovoni
(INSERM UMR1048, Institut des Maladies Métaboliques et Cardiovasculaires—I2MC, UMR1048, Institut National de la Santé et de la Recherche Médicale, Université de Toulouse)
- David Stegner
(Institute of Experimental Biomedicine, University Hospital and University of Würzburg)
- Michael Popp
(Institute of Experimental Biomedicine, University Hospital and University of Würzburg
Rudolf Virchow Center, University of Würzburg)
- Adrien Antkowiak
(INSERM UMR1048, Institut des Maladies Métaboliques et Cardiovasculaires—I2MC, UMR1048, Institut National de la Santé et de la Recherche Médicale, Université de Toulouse)
- Judith M.M. van Eeuwijk
(Institute of Experimental Biomedicine, University Hospital and University of Würzburg
Rudolf Virchow Center, University of Würzburg)
- Paquita Nurden
(Institute of Experimental Biomedicine, University Hospital and University of Würzburg
Institut Hospitalo-Universitaire LIRYC, Plateforme Technologique d’Innovation Biomédicale, Hôpital Xavier Arnozan)
- Simon Stritt
(Institute of Experimental Biomedicine, University Hospital and University of Würzburg
Rudolf Virchow Center, University of Würzburg)
- Tobias Heib
(Institute of Experimental Biomedicine, University Hospital and University of Würzburg
Rudolf Virchow Center, University of Würzburg)
- Katja Aurbach
(Institute of Experimental Biomedicine, University Hospital and University of Würzburg
Rudolf Virchow Center, University of Würzburg)
- Oguzhan Angay
(Rudolf Virchow Center, University of Würzburg)
- Deya Cherpokova
(Institute of Experimental Biomedicine, University Hospital and University of Würzburg
Rudolf Virchow Center, University of Würzburg)
- Niels Heinz
(Research Group for Gene Modification in Stem Cells, LOEWE Center for Cell and Gene Therapy Frankfurt/Main and the Paul-Ehrlich-Institute)
- Ayesha A. Baig
(Institute of Experimental Biomedicine, University Hospital and University of Würzburg
Rudolf Virchow Center, University of Würzburg)
- Maximilian G. Gorelashvili
(Institute of Experimental Biomedicine, University Hospital and University of Würzburg
Rudolf Virchow Center, University of Würzburg)
- Frank Gerner
(Institute of Experimental Biomedicine, University Hospital and University of Würzburg
Rudolf Virchow Center, University of Würzburg)
- Katrin G. Heinze
(Rudolf Virchow Center, University of Würzburg)
- Jerry Ware
(University of Arkansas for Medical Sciences)
- Georg Krohne
(Biocenter, University of Würzburg)
- Zaverio M. Ruggeri
(The Scripps Research Institute)
- Alan T. Nurden
(Institut Hospitalo-Universitaire LIRYC, Plateforme Technologique d’Innovation Biomédicale, Hôpital Xavier Arnozan)
- Harald Schulze
(Institute of Experimental Biomedicine, University Hospital and University of Würzburg)
- Ute Modlich
(Research Group for Gene Modification in Stem Cells, LOEWE Center for Cell and Gene Therapy Frankfurt/Main and the Paul-Ehrlich-Institute)
- Irina Pleines
(Institute of Experimental Biomedicine, University Hospital and University of Würzburg
Rudolf Virchow Center, University of Würzburg)
- Cord Brakebusch
(BRIC, Biomedical Institute, University of Copenhagen)
- Bernhard Nieswandt
(Institute of Experimental Biomedicine, University Hospital and University of Würzburg
Rudolf Virchow Center, University of Würzburg)
Abstract
Blood platelets are produced by large bone marrow (BM) precursor cells, megakaryocytes (MKs), which extend cytoplasmic protrusions (proplatelets) into BM sinusoids. The molecular cues that control MK polarization towards sinusoids and limit transendothelial crossing to proplatelets remain unknown. Here, we show that the small GTPases Cdc42 and RhoA act as a regulatory circuit downstream of the MK-specific mechanoreceptor GPIb to coordinate polarized transendothelial platelet biogenesis. Functional deficiency of either GPIb or Cdc42 impairs transendothelial proplatelet formation. In the absence of RhoA, increased Cdc42 activity and MK hyperpolarization triggers GPIb-dependent transmigration of entire MKs into BM sinusoids. These findings position Cdc42 (go-signal) and RhoA (stop-signal) at the centre of a molecular checkpoint downstream of GPIb that controls transendothelial platelet biogenesis. Our results may open new avenues for the treatment of platelet production disorders and help to explain the thrombocytopenia in patients with Bernard–Soulier syndrome, a bleeding disorder caused by defects in GPIb-IX-V.
Suggested Citation
Sebastian Dütting & Frederique Gaits-Iacovoni & David Stegner & Michael Popp & Adrien Antkowiak & Judith M.M. van Eeuwijk & Paquita Nurden & Simon Stritt & Tobias Heib & Katja Aurbach & Oguzhan Angay , 2017.
"A Cdc42/RhoA regulatory circuit downstream of glycoprotein Ib guides transendothelial platelet biogenesis,"
Nature Communications, Nature, vol. 8(1), pages 1-13, August.
Handle:
RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms15838
DOI: 10.1038/ncomms15838
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms15838. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.